Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

NCT06952621 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

390

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)

Interventions

DRUG: 3 cycles (Toripalimab + chemotherapy)
DRUG: 3 cycles（DCF）

Sponsor

Tang-Du Hospital